Please note: AABB reserves the right to make updates to this program.
Live Program Date: February 6, 2019 -
Master Program Number: 19EL-405 (see program format numbers below under Registration)
Educational Track: Technical/Clinical
Topic: Transfusion Medicine
Intended Audience: Hospital Blood Banks, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Physicians, Resident/Fellow, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers
Teaching Level: Intermediate
Director/Moderator: Isabella W. Martin, MD, Assistant Professor of Pathology, Medical Director of Microbiology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Speaker: Andrew Shih, MD, MSc, Clinical Assistant Professor, University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada
After participating in this educational activity, participants should be able to:
- List current AABB criteria for culturing residual components in the setting of suspected septic transfusion reaction.
- Discuss variation in transfusion reaction reporting and culturing rates between institutions.
- Apply modified criteria to decision-making about when to culture residual units to improve sensitivity for positive results.
In the setting of a suspected septic transfusion reaction, current AABB criteria can guide the decision-making process about when to culture residual units. However, these criteria as currently defined have some limitations. This program will present data from the SCARED study, a multicenter retrospective study which assessed institutional variability in residual unit and patient culturing practices and the yield of various approaches. Modified criteria are proposed which will improve the sensitivity of detecting a positive culture.
| || ||
|Single Viewer: On-Demand||
|Group Viewing: On-Demand||
Continuing Education Credit
AABB designates both the live and on-demand version of this eCast each to be eligible for 1 continuing education credits/contact hours for Physicians, California Nurse, California Lab Personnel, Florida Lab Personnel and General Participation credit. The final number of credits and credit types awarded for this program (live or on-demand) was determined by the program duration. For more information on each credit type please visit our
Continuing Education Credits webpage.
Disclosures for the planners of this event can be found here. Disclosures for the program faculty are provided at the beginning of the program.
Dr. Shih is a Clinical Assistant Professor at the University of British Columbia Faculty of Medicine and is the Transfusion Medicine Director at Vancouver General Hospital. His academic interests include optimizing appropriateness of transfusion, optimizing damage control resuscitation, and evidence-based development of best practice guidelines.